pd 98059 has been researched along with Adenocarcinoma Of Kidney in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H | 1 |
| Deng, L | 1 |
| Kanda, S | 1 |
| Kanetake, H | 1 |
| Miyata, Y | 1 |
2 other studies available for pd 98059 and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Sphingosine kinase-1 activation causes acquired resistance against Sunitinib in renal cell carcinoma cells.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Survival; Drug Resistance, Neop | 2014 |
Long-term exposure of human renal carcinoma cells to PD98059 induces epithelial-mesenchymal transition-like phenotype and enhanced motility.
Topics: Amides; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Enzyme Activation; Epithelium; Extra | 2008 |